Trials in Boston, Massachusetts
Here are the top 10 medical studies for alzheimer's disease in Boston, Massachusetts
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Donanemab for Alzheimer's Disease
Recruiting1 awardPhase 3
Newton, Massachusetts
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Monoclonal Antibodies
Gantenerumab for Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Providence, Rhode Island
This trial will study if treatment with an investigational study drug can prevent or slow the rate of Alzheimer's disease (AD)-causing accumulation of amyloid beta (Aβ). Part 1 will use Aβ positron emission tomography (PET) imaging to determine if treatment with the study drug prevents or slows the rate of Aβ pathological disease accumulation. Part 2 will evaluate the effect of early Aβ plaque reduction/prevention on disease progression by assessing downstream non-Aβ biomarkers of AD.
Trials With No Placebo
Monoclonal Antibodies
Foralumab for Mild Cognitive Impairment
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial will test the safety and effectiveness of Foralumab, a human antibody, in reducing inflammation in the brain to improve the immune response. The study will focus on participants with mild cognitive impairment
Behavioral Intervention
Reducing Antibiotic Use for Dementia
Recruiting3 awardsPhase 4
Boston, Massachusetts
This trial aims to compare different ways of managing suspected infections in nursing home residents with dementia. It wants to see if using a specific intervention can help reduce the use of antibiotics and other burdensome treatments compared
Radiopharmaceutical
Tau Tracer Comparison for Alzheimer's Disease
Recruiting1 awardPhase 1
Providence, Rhode Island
This trial uses special imaging agents to help visualize harmful brain proteins in people at risk of Alzheimer's disease. The agents make these proteins glow during scans, allowing doctors to see them clearly and monitor the disease.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.